Status
Conditions
Treatments
About
Exhaled volatile organic compounds will be measured during daytime with the goal to identifying circadian variability. The study incudes three subgroups: people without diabetes, people with type 1 diabetes, and people with type 2 diabetes. A total of 60 people will be recruited for the study.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria
Subgroup 1:
Subgroup 2:
Subgroup 3
Exclusion criteria
60 participants in 3 patient groups
Loading...
Central trial contact
Lilian Witthauer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal